IMMULITE®/IMMULITE® 1000 Systems BRM BR-MA (CA15-3) 10380948Recalls & reported problems
Siemens Healthcare Diagnostics Products Ltd · CA 15-3 - IMMULITE - RGT - 100 Tests · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414963655), received between Nov 17, 2017 and Nov 17, 2017 — classified as 1 malfunction.
2 other recalls cover devices cleared under the same FDA submission (K013984); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 17, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
SIEMENS TECHNICAL OPERATIONS INTERNAL INVESTIGATION HAS IDENTIFIED THAT DISCORDANT FALSELY LOW RESULTS WERE OBTAINED ON TWO INVESTIGATIONAL SAMPLES ON AN IMMULITE/ IMMULITE 1000 INSTRUMENT WHEN USING THE BR-MA (CA15-3) ASSAY. THE TWO INVESTIGATIONAL SAMPLES WERE SPIKED WITH BIOTIN AT MULTIPLE CONCENTRATIONS AND RUN FOR INVESTIGATIONAL PURPOSES ON AN IMMULITE/IMMULITE 1000 INSTRUMENT. THE RESULTS OF THE TWO SAMPLES SPIKED WITH 500 NG/ML OF BIOTIN WERE FALSELY LOW WITH A BIAS OF -71% AND -51% RESPECTIVELY COMPARED TO RESULTS OF THE TWO SAMPLES WITHOUT BIOTIN. THERE WERE NO PATIENT SAMPLES IMPACTED AS THIS WAS FOR INVESTIGATIONAL PURPOSES ONLY.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7041476 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K013984. One submission often covers many models, so check the product and lot details in each record.
- Z-1691-2018 · Jan 2, 2018 · TerminatedIMMULITE 2000/IMMULITE 2000 XPi BR-MA (CA15-3)
- Z-1677-2018 · Jan 2, 2018 · TerminatedIMMULITE /IMMULITE 1000 BR-MA (CA15-3)
Other SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR devices
- ADVIA Centaur® CA 15-3® 10327620Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR14 reports
- Atellica IM BR 10995478Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR11 reports
- IMMULITE® 2000 Systems BRM BR-MA (CA15-3) 10380983Siemens Healthcare Diagnostics Products Ltd · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR9 reports
- Atellica IM BR 10995477Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR8 reports
- ADVIA Centaur® BR +G 10333349Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR6 reports
- ADVIA Centaur® BR +G 10334837Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Dimension Vista® Flex® reagent cartridge CA15-3 10464344Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
- Atellica IM CA 15-3 10995485Siemens Healthcare Diagnostics Inc. · SYSTEM, TEST, IMMUNOLOGICAL, ANTIGEN, TUMOR4 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page